PMCB · PharmaCyte Biotech, Inc. · Debt
$0.36
+0.01 (+1.97%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 14, 2026
The latest filing no longer states the doubt (first flagged Jul 29, 2026).
View the 10-Q filed Sep 14, 2026Market Cap
$3.76M
Shares
10.74M
Volume · Oct 27
47.71K
Avg daily vol (3M)
195.78K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of loans payable | 2021-04-30 | USD 0 | 10-K filed 2021-08-10 |
| Noncurrent loans payable | 2021-04-30 | USD 0 | 10-K filed 2021-08-10 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.